Literature DB >> 3606234

Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients.

F Fekete, J Belghiti, D Cherqui, F Langonnet, B Gayet.   

Abstract

Esophagogastrectomy for carcinoma of the esophagus or cardia has been performed in 23 patients with histologically proven hepatic cirrhosis. All but two patients were classified as Child's class A and all but three had a prothrombin time over 60% of normal values. Twenty-two esophagogastrostomies were performed through a separate abdominal and right thoracic approach in 15 patients, a left thoracoabdominal approach in five patients, and without thoracotomy in two patients. One patient had a colon interposition. Six patients died after operation (26%) as a result of anastomotic leakage in two patients, hepatorenal in three patients and portal thrombosis in one patient. The type of procedure did not influence mortality. The most common postoperative complication was the development of ascites (65%), and when associated with hepatorenal syndrome there was a significant mortality (p less than 0.05). Sepsis was present in the terminal stages of all nonsurvivors. A prothrombin time less than or equal to 60% of normal values was the only significant preoperative predictive factor of mortality, with none of the three patients surviving below this level (p less than 0.05). It is concluded that the presence of cirrhosis is not a contraindication to esophagogastrectomy for carcinoma when curative resection can be undertaken. Hepatic reserve is the determinant factor of operative prognosis. Operative risk is acceptable if patients are classified as Child's class A and prothrombin time is over 60% of normal values. Operation should be delayed when acute alcoholic hepatitis is present. Intraoperative discovery of cirrhosis is not a contraindication to resection where the above criteria are met. This strict selection allows one to anticipate a lower mortality rate.

Entities:  

Mesh:

Year:  1987        PMID: 3606234      PMCID: PMC1492920          DOI: 10.1097/00000658-198707000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Therapeutic portacaval shunt. Preliminary data on controlled trial and morbid effects of acute hyaline necrosis.

Authors:  W P Mikkelsen
Journal:  Arch Surg       Date:  1974-03

2.  A new technique for treating esophageal varices.

Authors:  M Sugiura; S Futagawa
Journal:  J Thorac Cardiovasc Surg       Date:  1973-11       Impact factor: 5.209

3.  [Current treatment of thoracic oesophageal carcinoma (author's transl)].

Authors:  F Fekete; F Langonnet; B Gayet; P Breil
Journal:  Nouv Presse Med       Date:  1982-01-16

4.  EEA stapler and omental graft in esophagogastrectomy: experience with 30 intrathoracic anastomoses for cancer.

Authors:  F Fekete; P Breil; H Ronsse; J C Tossen; F Langonnet
Journal:  Ann Surg       Date:  1981-06       Impact factor: 12.969

5.  Portal vein thrombosis associated with cirrhosis: clinical importance.

Authors:  I J Sarfeh
Journal:  Arch Surg       Date:  1979-08

6.  Surgical therapy of advanced esophageal cancer. A critical appraisal.

Authors:  B Caracci; P Garvin; D L Kaminski
Journal:  Am J Surg       Date:  1983-12       Impact factor: 2.565

7.  Morbidity and mortality after operation in nonbleeding cirrhotic patients.

Authors:  R C Doberneck; W A Sterling; D C Allison
Journal:  Am J Surg       Date:  1983-09       Impact factor: 2.565

8.  Outcome in cirrhotic patients with acute alcoholic hepatitis after emergency portacaval shunt for bleeding esophageal varices.

Authors:  R H Bell; K Miyai; M J Orloff
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

9.  Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia.

Authors:  F H Ellis; S P Gibb; E Watkins
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

10.  Cholecystectomy in cirrhotic patients: a formidable operation.

Authors:  G V Aranha; S J Sontag; H B Greenlee
Journal:  Am J Surg       Date:  1982-01       Impact factor: 2.565

View more
  13 in total

1.  Mediastinoscopy-assisted esophagectomy for esophageal cancer in patients with serious comorbidities.

Authors:  Naohiko Koide; Daisuke Takeuchi; Akira Suzuki; Shinichi Miyagawa
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Achalasia in a patient with gastroesophageal varices: problematic treatment decisions.

Authors:  Hugo Pinillos; Peter Legnani; Thomas Schiano
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  Surgery for gastric cancer in patients with cirrhosis.

Authors:  H Isozaki; K Okajima; T Ichinona; K Fujii; E Nomura; N Izumi
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Gastric cancer surgery for patients with liver cirrhosis.

Authors:  Yoshiyuki Ikeda; Tatsuo Kanda; Shin-Ichi Kosugi; Kazuhito Yajima; Atsushi Matsuki; Tsutomu Suzuki; Katsuyoshi Hatakeyama
Journal:  World J Gastrointest Surg       Date:  2009-11-30

5.  Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction.

Authors:  Keun Won Ryu; Jun Ho Lee; Young Woo Kim; Joong-Won Park; Jae-Moon Bae
Journal:  World J Surg       Date:  2005-05       Impact factor: 3.352

6.  Drainage after elective hepatic resection. A randomized trial.

Authors:  J Belghiti; M Kabbej; A Sauvanet; V Vilgrain; Y Panis; F Fekete
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

7.  Esophageal resection and by-pass: a 6 year experience with a low postoperative mortality.

Authors:  J M Collard; J B Otte; M Reynaert; L Michel; M A Carlier; P J Kestens
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

8.  Herniorrhaphy and concomitant peritoneovenous shunting in cirrhotic patients with umbilical hernia.

Authors:  J Belghiti; F Desgrandchamps; O Farges; F Fékété
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

9.  Treatment selection for gastric cancer with portal hypertension: clinical management.

Authors:  Zhou-Xiang Jin; Yong-Yong Ma; Xiang-Yu Wang; Li-Jun Li; Zhi-Qiang Zheng
Journal:  Gastric Cancer       Date:  2013-06-28       Impact factor: 7.370

10.  Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysis.

Authors:  Florence Trivin; Eveline Boucher; Elodie Vauléon; Isabelle Cumin; Elisabeth Le Prisé; Odile Audrain; Jean-Luc Raoul
Journal:  J Oncol       Date:  2009-12-22       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.